The role of the second extracellular loop of norepinephrine transporter, neurotrophin-3 and tropomyosin receptor kinase C in T cells: a peripheral biomarker in the etiology of schizophrenia
Rodrigues Amorim, Daniela; Iglesias Martínez Almeida, Marta; Rivera Baltanás, Tania; Fernández Palleiro, Patricia; Freiría Martínez, Luis; Rodríguez Jamardo, Cynthia; Comís Tuche, María; Vallejo Curto, María del Carmen; Álvarez Ariza, María; López García, Marta; Heras, Elena de las; García Caballero, Alejandro; Olivares, Jose Manuel; Spuch Calvar, Carlos
DATA:
2021-08-07
IDENTIFICADOR UNIVERSAL: http://hdl.handle.net/11093/2462
VERSIÓN EDITADA: https://www.mdpi.com/1422-0067/22/16/8499
TIPO DE DOCUMENTO: article
RESUMO
The neurobiology of schizophrenia is multifactorial, comprising the dysregulation of several biochemical pathways and molecules. This research proposes a peripheral biomarker for schizophrenia that involves the second extracellular loop of norepinephrine transporter (NEText), the tropomyosin receptor kinase C (TrkC), and the neurotrophin-3 (NT-3) in T cells. The study of NEText, NT-3, and TrkC was performed in T cells and plasma extracted from peripheral blood of 54 patients with schizophrenia and 54 healthy controls. Levels of NT-3, TrkC, and NET were significantly lower in plasma and T cells of patients compared to healthy controls. Co-immunoprecipitation (co-IPs) showed protein interactions with Co-IP NEText–NT-3 and Co-IP NEText–TrkC. Computational modelling of protein–peptide docking by CABS-dock provided a medium–high accuracy model for NT-3–NEText (4.6935 Å) and TrkC–NEText (2.1365 Å). In summary, immunocomplexes reached statistical relevance in the T cells of the control group contrary to the results obtained with schizophrenia. The reduced expression of NT-3, TrkC, and NET, and the lack of molecular complexes in T cells of patients with schizophrenia may lead to a peripheral dysregulation of intracellular signaling pathways and an abnormal reuptake of norepinephrine (NE) by NET. This peripheral molecular biomarker underlying schizophrenia reinforces the role of neurotrophins, and noradrenergic and immune systems in the pathophysiology of schizophrenia.